|Articles|November 1, 2013
- Applied Clinical Trials-11-01-2013
- Volume 22
- Issue 11
Applied Clinical Trials Digital Edition - November 2013
Regulatory: Successful Phase III Trial Monitoring Trial Design: Multi-regional Trials Data Evaluation Also in this issue: Compromise in Europe's Rule Debate True Potential of Adaptive Trial Designs Bring Your Own Device
Advertisement
Articles in this issue
almost 13 years ago
Sponsors Struggle with Data Disclosure Requirementsalmost 13 years ago
Evaluation of Data for Multi-Regional Trials: A Three-Layer Approachalmost 13 years ago
Cost Per Visit Trends Higher for Less Established Regionsalmost 13 years ago
Modeling Successful Phase III Trialsalmost 13 years ago
GCP's Future: Looking Ahead to the Next 20 Yearsalmost 13 years ago
Crunch-Time for Europe's Clinical Trials Rulesalmost 13 years ago
Device Independence is the Future of Clinical Trialsalmost 13 years ago
Business and People November 2013almost 13 years ago
Adoption of Adaptive Trial Designs Poised to AccelerateAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
When the Slack Runs Out: AI and the CRO Operating Model
2
Why Site Payment Inconsistency Has Persisted for So Long
3
Why Payment Performance Has Become a Competitive Differentiator for Sponsors
4
Speed, Discipline, and the New Rules of Biotech Development: Q&A with Stella K. Vnook, PhD, Kaida BioPharma and Aviva Ventures
5